JPWO2022015922A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022015922A5
JPWO2022015922A5 JP2023503124A JP2023503124A JPWO2022015922A5 JP WO2022015922 A5 JPWO2022015922 A5 JP WO2022015922A5 JP 2023503124 A JP2023503124 A JP 2023503124A JP 2023503124 A JP2023503124 A JP 2023503124A JP WO2022015922 A5 JPWO2022015922 A5 JP WO2022015922A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
acid sequence
trp
phe
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023503124A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023535366A (ja
JP2023535366A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/041737 external-priority patent/WO2022015922A1/en
Publication of JP2023535366A publication Critical patent/JP2023535366A/ja
Publication of JP2023535366A5 publication Critical patent/JP2023535366A5/ja
Publication of JPWO2022015922A5 publication Critical patent/JPWO2022015922A5/ja
Pending legal-status Critical Current

Links

JP2023503124A 2020-07-16 2021-07-15 G12v変異を有するrasに対するhlaクラスii拘束性drb t細胞受容体 Pending JP2023535366A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063052502P 2020-07-16 2020-07-16
US63/052,502 2020-07-16
PCT/US2021/041737 WO2022015922A1 (en) 2020-07-16 2021-07-15 Hla class ii-restricted drb t cell receptors against ras with g12v mutation

Publications (3)

Publication Number Publication Date
JP2023535366A JP2023535366A (ja) 2023-08-17
JP2023535366A5 JP2023535366A5 (https=) 2024-07-18
JPWO2022015922A5 true JPWO2022015922A5 (https=) 2024-07-18

Family

ID=77265247

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023503124A Pending JP2023535366A (ja) 2020-07-16 2021-07-15 G12v変異を有するrasに対するhlaクラスii拘束性drb t細胞受容体

Country Status (9)

Country Link
US (1) US20230257440A1 (https=)
EP (1) EP4182029B1 (https=)
JP (1) JP2023535366A (https=)
KR (1) KR20230046294A (https=)
CN (1) CN116348484A (https=)
AU (1) AU2021309958A1 (https=)
CA (1) CA3185483A1 (https=)
ES (1) ES3063075T3 (https=)
WO (1) WO2022015922A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2022227029A1 (en) 2021-02-26 2023-08-31 New York University Compositions and methods comprising antibodies that bind to covalent peptide conjugates

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003265948B8 (en) 2002-09-06 2009-09-03 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy
US8383099B2 (en) 2009-08-28 2013-02-26 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Adoptive cell therapy with young T cells
ES2635335T3 (es) * 2010-09-20 2017-10-03 Biontech Cell & Gene Therapies Gmbh Receptores de células T específicos de antígeno y epítopos de células T
WO2012129201A1 (en) 2011-03-22 2012-09-27 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods of growing tumor infiltrating lymphocytes in gas-permeable containers
MX384919B (es) * 2014-11-26 2025-03-14 Us Health Receptores de células t de kras anti-mutado.
JP7185524B2 (ja) * 2015-09-15 2022-12-07 アメリカ合衆国 Hla-cw8拘束性の変異krasを認識するt細胞受容体
EP3684799A1 (en) * 2017-09-20 2020-07-29 The U.S.A. as represented by the Secretary, Department of Health and Human Services Hla class ii restricted t cell receptors against mutated ras
EP3720478A1 (en) * 2017-12-04 2020-10-14 The United States of America, as represented by the Secretary, Department of Health and Human Services Hla class i-restricted t cell receptors against mutated ras
EP3749349A4 (en) * 2018-02-10 2021-11-24 Berkeley Lights, Inc. MUTANT IDH1 SPECIFIC T CELL RECEPTOR

Similar Documents

Publication Publication Date Title
Boyson et al. Identification of a novel MHC class I gene, Mamu-AG, expressed in the placenta of a primate with an inactivated G locus
JP7256794B2 (ja) 変異型rasに対するhlaクラスii拘束性t細胞受容体
RU2752528C2 (ru) Композиции и библиотеки, содержащие рекомбинантные полинуклеотиды, кодирующие Т-клеточные рецепторы, и способы применения рекомбинантных Т-клеточных рецепторов
JP2021505136A5 (https=)
KR20230079259A (ko) Kras 돌연변이 특이적 t세포 수용체의 스크리닝 및 항종양 용도
GB2609760A (en) HLA Class I-restricted T cell receptors against RAS with G12D mutation
JP2020534828A5 (https=)
EP3615565A1 (en) Tcr and peptides
CN111032686B (zh) 血液恶性肿瘤的治疗
JPH08109199A (ja) T細胞抗原受容体に対する抗体
Fellah et al. Conserved structure of amphibian T-cell antigen receptor beta chain.
JP7742354B2 (ja) G12v変異を有するrasに対するhlaクラスii拘束性t細胞受容体
CN113621048A (zh) T细胞抗原受体、其多聚体复合物及其制备方法和应用
JP2023534241A (ja) G12d変異を有するrasに対するhlaクラスii拘束性drb t細胞受容体
JPWO2022015922A5 (https=)
JPWO2020154275A5 (https=)
JPWO2022015694A5 (https=)
Wagner et al. Structural elements underlying the high binding affinity of human cytomegalovirus UL18 to leukocyte immunoglobulin-like receptor-1
US8658177B2 (en) Promiscuous HER-2/Neu CD4 T cell epitopes
CN116348484A (zh) 针对含有g12v突变的ras的hla-ii类限制性drb t细胞受体
GB2614166A (en) T cell receptors recognizing R273C or Y220C mutations in P53
Hayball et al. The immune function of MHC class II molecules mutated in the putative superdimer interface
JPWO2022051449A5 (https=)
NZ805541A (en) Hla class i-restricted t cell receptors against mutated ras
CN119256084A (zh) 血液系统恶性肿瘤的治疗